Iterum Therapeutics plc (ITRMF) Payables (2017 - 2025)
Iterum Therapeutics (ITRMF) posted quarterly Payables of $577000.0 for Q3 2025, down 30.9% year-over-year from $835000.0 in Q3 2024, and down 51.47% quarter-over-quarter from $1.2 million in Q2 2025.
Iterum Therapeutics plc (ITRMF) Payables (2017 - 2025) Analysis & Trends
Iterum Therapeutics' Payables history runs 9 years deep, the most recent figure standing at $577000.0 for Q3 2025.
- In Q3 2025, Payables fell 30.9% year-over-year to $577000.0; the TTM figure through Sep 2025 stood at $577000.0 (down 30.9% YoY), while the FY2024 annual figure was $251000.0, down 94.98% from the prior year.
- Payables for Q3 2025 stood at $577000.0, down from $1.2 million in the prior quarter.
- The five-year high for Payables was $30.7 million in Q1 2021, with the low at $251000.0 in Q4 2024.
- The 5-year median for Payables is $3.0 million (2024), against an average of $5.6 million.
- The sharpest annual moves came in 2023 and 2024: Payables surged 203.92% in 2023, then sank 94.98% in 2024.
- Iterum Therapeutics' Payables stood at $6.9 million in 2021, then slumped by 57.18% to $3.0 million in 2022, then surged by 68.22% to $5.0 million in 2023, then tumbled by 94.98% to $251000.0 in 2024, then surged by 129.88% to $577000.0 in 2025.
- Business Quant data shows ITRMF's Payables at $577000.0 in Q3 2025, $1.2 million in Q2 2025, and $413000.0 in Q1 2025.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 577,000.00 |
| Jun 30, 2025 | 1.19 Mn |
| Mar 31, 2025 | 413,000.00 |
| Dec 31, 2024 | 251,000.00 |
| Sep 30, 2024 | 835,000.00 |
| Jun 30, 2024 | 822,000.00 |
| Mar 31, 2024 | 2.97 Mn |
| Dec 31, 2023 | 5.00 Mn |
| Sep 30, 2023 | 5.59 Mn |
| Jun 30, 2023 | 3.87 Mn |
| Mar 31, 2023 | 2.42 Mn |
| Dec 31, 2022 | 2.97 Mn |
| Sep 30, 2022 | 1.84 Mn |
| Jun 30, 2022 | 2.41 Mn |
| Mar 31, 2022 | 5.14 Mn |
| Dec 31, 2021 | 6.94 Mn |
| Sep 30, 2021 | 9.46 Mn |
| Jun 30, 2021 | 23.81 Mn |
| Mar 31, 2021 | 30.72 Mn |
| Dec 31, 2020 | 29.68 Mn |